Journal Menu
► ▼ Journal Menu-
- Cancers Home
- Aims & Scope
- Editorial Board
- Reviewer Board
- Topical Advisory Panel
- Instructions for Authors
- Special Issues
- Topics
- Sections & Collections
- Article Processing Charge
- Indexing & Archiving
- Editor’s Choice Articles
- Most Cited & Viewed
- Journal Statistics
- Journal History
- Journal Awards
- Society Collaborations
- Conferences
- Editorial Office
Journal Browser
► ▼ Journal BrowserNeed Help?
Announcements
15 May 2026
Cancers | 2025 Editor’s Choice Articles and Special Issues from the “Cancer Therapy” Section
Editor’s Choice Articles are selected based on suggestions from Cancers’ global team of Academic Editors. The Editors select a small number of recently published articles that they consider particularly interesting to our readers or important in their respective fields of research. You are invited to read the 2025 Editor’s Choice Articles, a curated list of high-quality articles from Cancers (ISSN: 2072-6694), and explore Special Issues related to cancer therapy. The full list of Editor’s Choice Articles can be viewed on the following website: https://www.mdpi.com/journal/cancers/editors_choice.
The list of relevant papers can be seen below:
“Cyclin-Dependent Kinase Inhibition in Prostate Cancer: Past, Present, and Future”
by Matthew Siskin, Minas P. Economides and David R. Wise
Cancers 2025, 17(5), 774; https://doi.org/10.3390/cancers17050774
Available online: https://www.mdpi.com/2072-6694/17/5/774
“Prognostic Value of PLR, SIRI, PIV, SII, and NLR in Non-Muscle Invasive Bladder Cancer: Can Inflammatory Factors Influence Pathogenesis and Outcomes?”
by Francesco Pio Bizzarri, Marco Campetella, Pierluigi Russo, Giuseppe Palermo, Seyed Koosha Moosavi, Francesco Rossi, Lorenzo D’Amico, Antonio Cretì, Filippo Gavi, Enrico Panio et al.
Cancers 2025, 17(13), 2189; https://doi.org/10.3390/cancers17132189
Available online: https://www.mdpi.com/2072-6694/17/13/2189
“Optimizing Osimertinib for NSCLC: Targeting Resistance and Exploring Combination Therapeutics”
by Yan-You Liao, Chia-Luen Tsai and Hsiang-Po Huang
Cancers 2025, 17(3), 459; https://doi.org/10.3390/cancers17030459
Available online: https://www.mdpi.com/2072-6694/17/3/459
“Denosumab vs. Zoledronic Acid for Metastatic Bone Disease: A Comprehensive Systematic Review and Meta-Analysis of Randomized Controlled Trials“
by Benjamin G. Wajda, Leah E. Ferrie, Annalise G. Abbott, Golpira Elmi Assadzadeh, Michael J. Monument and Joseph K. Kendal
Cancers 2025, 17(3), 388; https://doi.org/10.3390/cancers17030388
Available online: https://www.mdpi.com/2072-6694/17/3/388
“Anti-EGFR Therapy in Metastatic Colorectal Cancer: Identifying, Tracking, and Overcoming Resistance”
by Luís Felipe Leite, Mariana Macambira Noronha, Junior Samuel Alonso de Menezes, Lucas Diniz da Conceição, Luiz F. Costa Almeida, Anelise Poluboiarinov Cappellaro, Marcos Belotto, Tiago Biachi de Castria, Renata D’Alpino Peixoto and Thais Baccili Cury Megid
Cancers 2025, 17(17), 2804; https://doi.org/10.3390/cancers17172804
Available online: https://www.mdpi.com/2072-6694/17/17/2804
“Adrenal Mass Evaluation: Suspicious Radiological Signs of Malignancy”
by Giulia Grazzini, Silvia Pradella, Federica De Litteris, Antonio Galluzzo, Matilde Anichini, Francesca Treballi, Eleonora Bicci and Vittorio Miele
Cancers 2025, 17(5), 849; https://doi.org/10.3390/cancers17050849
Available online: https://www.mdpi.com/2072-6694/17/5/849
“Next-Generation Immunotherapy for Hepatocellular Carcinoma: Mechanisms of Resistance and Novel Treatment Approaches”
by Shabnam Eghbali and Thatcher Ross Heumann
Cancers 2025, 17(2), 236; https://doi.org/10.3390/cancers17020236
Available online: https://www.mdpi.com/2072-6694/17/2/236
“AI and Polyp Detection During Colonoscopy”
by Marco Spadaccini, Maddalena Menini, Davide Massimi, Tommy Rizkala, Roberto De Sire, Ludovico Alfarone, Antonio Capogreco, Matteo Colombo, Roberta Maselli, Ludovico Alfarone et al.
Cancers 2025, 17(5), 797; https://doi.org/10.3390/cancers17050797
Available online: https://www.mdpi.com/2072-6694/17/5/797
Special Issues:
“Proton Therapy of Cancer Treatment”
Guest Editors: Dr. Minglei Kang, Dr. Benjamin Durkee and Dr. Kuo Men
Submission deadline: 1 June 2026
“Advances in Soft Tissue and Bone Sarcoma (2nd Edition)”
Guest Editor: Dr. Catrin Sian Rutland
Submission deadline: 25 June 2026
“New Challenges for Gastric Cancer—Gut Microbiota, Post-eradication and Chemotherapy”
Guest Editors: Dr. Kazunari Murakami and Dr. Kazuhiro Mizukami
Submission deadline: 30 June 2026
“Novel Treatments for Ocular and Periocular Cancers”
Guest Editor: Dr. Vidhya R. Rao
Submission deadline: 30 June 2026
You are invited to read and submit relevant papers to the journal Cancers using the following link:
https://www.mdpi.com/journal/cancers.
Cancers Editorial Office